At some point likely in the not too distant future I expect small cap biotechs to have a huge rally and outperform the broader markers substantially. 10 year charts for context/perspective: 1️⃣ $SPY up ~160% 2️⃣ $XLV (large cap pharma) up not quite 100% 3️⃣ $XBI (small-mid cap

Okay, now that $ABCL cost basis is hitting like crack

Today, I am pleased to announce that companies may now submit statements of interest for participation in the Commissioner's National Priority Voucher pilot program, which offers drug developers enhanced communication throughout the development process and dramatically shortens

AbCellera Biologics funded Abderatx.com #AACR25 new molecule likely from $abcl ABD320, a novel 5T4-targeted radiopharmaceutical with favorable tumor-to-normal tissue biodistribution and single-dose efficacy in preclinical cancer models abderatx.com/publications/

$ABCL quarterly chart

I can deal with biotech being in an economic down cycle but what does irk me somewhat is that biotech culture is so buttoned up we barely got to enjoy the up cycle Like I was invited to literally zero cocaine junkets to ibiza during the zirp years. I was in the lab like a nerd

Isn’t it funny that the discourse around AI revolves around this intangible entity promising rational wonders, yet it’s heavily dependent on the physical world? $NVDA is the proof. The same thing happens with biotech, the best wet lab will bring wonders to healthcare.

x.com/i/article/1948…

**A grand unified theory on what will happen in biotech in the next 10-20 years** the two major forces reshaping industrial biotech in the next decade are: 1. China 2. AI - and they're critically linked how? China's low R&D cost basis democratizes execution by providing

$ABSI prices $50M offering. 16.67M shares at $3/share

Pretty dishonest sell thesis for $ABCL imo. The author doesn’t even mention the $ABBV collaboration or the incoming CMC and GMP facility opening. If AbCellera were to be acquired, the price wouldn’t be below $1.5B, so good luck selling buddy. seekingalpha.com/article/480355…

It is becoming increasingly more obvious to me that $ABCL is the next big winner in the coming years. Started buying at $1.98 and will continue to buy dips on the ride up. Understand that this company is already programmed to become a massive player. This should sound crazy,

$ABCL 8th week in the green and two weeks away from earnings. Stay focused 🫡

The shorts keep increasing, and it's shown in the candles. Some shorts are - 100% and should be liquidated anytime A new trading range is carved out in the price $abcl AbCellera AbCellera

The court case of $ABCL vs $BRKR is nearing resolution after 5 years. I am not an expert, so see ChatGPT milestones and upcoming events The court case looks really good for AbCellera, and we have seen the impact of this case news on the stock. Let’s wait for any news during fall